MonoMax for Abdominal Wall Closure
MULTIMAC
A Multicentre, International, Prospective Post-market Clinical Follow-up to Evaluate MonoMax for Abdominal Wall Closure
1 other identifier
observational
200
2 countries
3
Brief Summary
A great number of different suture techniques and suture materials are in use in order to reconstitute the abdominal wall integrity, but there is no surgical gold standard for abdominal wall closure until today. Various Meta-Analyses and randomized controlled trials have been performed, which compared non-absorbable or long-term absorbable versus rapid absorbable suture materials or monofilament versus multifilament suture materials, or continuous versus interrupted suture techniques respectively. This lack of evidence has the following outcome: burst abdomen is observed in 1-3% of patients within the first days after a laparotomy. The incidence of abdominal wall hernias 12 months postoperatively is estimated to be up to 20% (range 9 to 20%) . Wound infections develop in 3 to 21% of patients undergoing a median laparotomy within the first 30 days. At present most surgeons favour monofilament long-absorbable continuous sutures as the most suitable material for closing abdominal wounds after midline laparotomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2013
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 5, 2013
CompletedFirst Posted
Study publicly available on registry
July 17, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedDecember 13, 2024
December 1, 2024
2.6 years
July 5, 2013
December 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Frequency of reoperation due to burst abdomen
participants will be followed for the duration of hospital stay, an expected average of 10 days
Frequency of wound infections
participants will be followed for the duration of hospital stay, an expected average of 10 days
Secondary Outcomes (2)
Incidence of wound healing until day of discharge
participants will be followed for the duration of hospital stay, an expected average of 10 days
Length of hospital stay
participants will be followed for the duration of hospital stay, an expected average of 10 days
Study Arms (1)
MonoMax
Elective primary laparotomy
Interventions
Abdominal wall will be closed with MonoMax after an elective primary laparotomy.
Eligibility Criteria
adult patients
You may qualify if:
- Age 18 years and older
- Elective primary laparotomy
- Written informed consent
You may not qualify if:
- Peritonitis
- Emergency surgery
- Severe psychiatric and neurologic disease
- Drug- and / or alcohol abuse according to local standard
- Lack of informed consent
- Current immunosuppressive therapy
- Chemotherapy within the 2 weeks before operation
- Radiotherapy of the abdomen completed less than 8 before surgery
- Pregnant or breast-feeding women
- Coagulopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aesculap AGlead
- B.Braun Surgical SAcollaborator
Study Sites (3)
Chirurgicka klinika, Fakultni nemocnine
Hradec Králové, 500 05, Czechia
Chirurgicka klinika, Fakultni nemocnine
Olomouc, 77520, Czechia
Central Emergency Military Hospital
Bucharest, Romania
Related Publications (3)
Fink C, Baumann P, Wente MN, Knebel P, Bruckner T, Ulrich A, Werner J, Buchler MW, Diener MK. Incisional hernia rate 3 years after midline laparotomy. Br J Surg. 2014 Jan;101(2):51-4. doi: 10.1002/bjs.9364. Epub 2013 Nov 26.
PMID: 24281948BACKGROUNDFischer L, Baumann P, Husing J, Seidlmayer C, Albertsmeier M, Franck A, Luntz S, Seiler CM, Knaebel HP. A historically controlled, single-arm, multi-centre, prospective trial to evaluate the safety and efficacy of MonoMax suture material for abdominal wall closure after primary midline laparotomy. ISSAAC-Trial [NCT005725079]. BMC Surg. 2008 Jul 21;8:12. doi: 10.1186/1471-2482-8-12.
PMID: 18644124BACKGROUNDAlbertsmeier M, Seiler CM, Fischer L, Baumann P, Husing J, Seidlmayer C, Franck A, Jauch KW, Knaebel HP, Buchler MW. Evaluation of the safety and efficacy of MonoMax(R) suture material for abdominal wall closure after primary midline laparotomy-a controlled prospective multicentre trial: ISSAAC [NCT005725079]. Langenbecks Arch Surg. 2012 Mar;397(3):363-71. doi: 10.1007/s00423-011-0884-6. Epub 2011 Dec 20.
PMID: 22183105BACKGROUND
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 5, 2013
First Posted
July 17, 2013
Study Start
February 1, 2013
Primary Completion
September 1, 2015
Study Completion
December 1, 2015
Last Updated
December 13, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share